HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 10 December 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  20 papers were listed this time. Here's a few  in our areas of research interest:

Behl AS, Goddard KA, Flottemesch TJ, et al. Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer. J Natl Cancer Inst. 2012 Nov 28. [Epub ahead of print] PubMed PMID: 23197490.

Pollock RF, Curtis BH, Smith-Palmer J, et al. A UK Analysis of the Cost-Effectiveness of Humalog Mix75/25 and Mix50/50 Versus Long-Acting Basal Insulin. Adv Ther. 2012 Nov 22. [Epub ahead of print] PubMed PMID: 23179373.

Hiligsmann M, Sedrine WB, Reginster JY. Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women. J Bone Miner Res. 2012 Nov 19. [Epub ahead of print] PubMed PMID: 23165656.